Evaluation of clinical, morphopathological and therapeutic prognostic factors in rectal cancer. Experience of a tertiary oncology center

Journal of B.U.ON.

Volumn 20, Issue 1, 2015, Pages 92-99

  Vlad, Catalin ^a   Kubelac, Paul ^b   Vlad, Diana ^b   Irimie, Alexanrdu ^a   Cadariu, Patriciu Achimas ^a  

^a THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Lymphatic invasion; Perineural invasion; Prognosis; Rectal cancer; TNM stage; Venous invasion

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGY WARD; OVERALL SURVIVAL; PERINEURAL INVASION; PROGNOSTIC ASSESSMENT; PROGRESSION FREE SURVIVAL; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR INVASION; AGE; COMPARATIVE STUDY; EVALUATION STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECTAL NEOPLASMS; RISK FACTOR; ROMANIA; TERTIARY CARE CENTER; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; ROMANIA; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928695978     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403.
2. Cunningham D, Atkin W, Lenz H-J et al. Colorectal cancer. The Lancet 2010;375:1030-1047.
3. Edge S, Compton C. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol 2010;17:1471-1474.
4. Wibe A, Law WL, Fazio V, Delaney CP. Tailored rectal cancer treatment - A time for implementing contemporary prognostic factors? Colorectal Dis 2013;15:1333-1342.
5. Efremidou EI, Liratzopoulos N, Papageorgiou SM et al. Colorectal carcinoma: correlation between age, gender and subsite distribution. Chirurgia (Bucur) 2008;103:659-663.
6. Gupta AK, Melton LJ 3rd, Petersen GM et al. Changing trends in the incidence, stage, survival, and screen-de- tection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol 2005;3:150-158.
7. Angell-Andersen E, Tretli S, Coleman MP, Langmark F, Grotmol T. Colorectal cancer survival trends in Norway 1958-1997. Eur J Cancer 2004;40:734-742.
8. Semmens JB, Platell C, Threlfall TJ, Holman CD. A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia. Aust N Z J Surg 2000;70:11-18.
9. Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2009-pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
10. Fernandez E, La-Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001;84:722-727.
11. Grodstein F, Newcomb PA, Stampfer MJ. Postmen-opausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-582.
12. Wolters U, Stutzer H, Isenberg J. Gender related survival in colorectal cancer. Anticancer Res 1996;16:1281-1289.
13. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003;90:711-715.
14. Hendifar A, Yang D, Lenz F et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 2009;15:6391-6397.
15. Koo JH, Jalaludin B, Wong SK, Kneebone A, Connor SJ, Leong RW. Improved survival in young women with colorectal cancer. Am J Gastroenterol 2008;103:1488-1495.
16. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003;69:866-872.
17. Wolmark N, Wieand HS, Rockette HF et al. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg 1983;198:743-752.
18. Zucchetti F, Negro F, Matera D, Bolognini S, Mafucci S. Colorectal cancer: obstruction is an independent negative prognostic factor after radical resection. Ann Ital Chir 2002.73:421-425.
19. Vasile L, Olaru A, Munteanu M, Plesea IE, Surlin V, Tudorascu C. Prognosis of colorectal cancer: clinical, pathological and therapeutic correlation. Rom J Morphol Embryol 2012;53:383-391.
20. Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 2005;61:426-431.
21. Wright FC, Law CH, Last L et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 2003;10:903-909.
22. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 2010;53:65-70.
23. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pTl or pT2 well-dif- ferentiated colorectal adenocarcinoma. Dis Colon Rectum 2002;45:628-634.
24. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99:433-441.
25. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980;67:439-442.
26. Desolneux G, Burtin P, Lermite E, Bergamaschi R, Hamy A, Arnaud JP. Prognostic factors in node-neg- Ative colorectal cancer: a retrospective study from a prospective database. Int J Colorectal Dis 2010;25:829-834.
27. Betge J, Schneider NI, Pollheimer MJ et al. Is there a rationale to record lymphatic invasion in node-posi- tive colorectal cancer? J Clin Pathol 2012;65:847-850.
28. Koca D, Binicier C, Oztop I, Yavuzsen T, Ellidokuz H, Yilmaz U. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer. J BUON 2012;17:291-298.
29. Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer. Pancreas 2003;26:322-325.
30. Liebig C, Ayala G, Wilks J et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 2009;27:5131-5137.
31. Tural D, Ozturk M, Selcukbiricik F et al. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. J BUON 2013;18:385-390.
32. Quah H-M, Chou JF, Gonen M et al. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008;113:57-64.
33. Ortholan C, Francois E, Thomas O et al. Role of radi-otherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum 2006;49:302-310.
34. Kim D-W, Kim DY, Kim TH et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006; 106:1694-1700.
35. Rodel C, Martus P, Papadopoulos T et al. Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer. J Clin Oncol 2005;23:8688-8696.